Xspray Pharma AB's market cap is currently kr1.12B. The company's EPS TTM is kr-1.179; its P/E ratio is ―; Xspray Pharma AB is scheduled to report earnings on August 15, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
